Literature DB >> 22745921

The placenta in preeclampsia.

James M Roberts1, C Escudero.   

Abstract

The root cause of preeclampsia is the placenta. Preeclampsia begins to abate with the delivery of the placenta and can occur in the absence of a fetus but with the presence of trophoblast tissue with hydatidiform moles. In view of this, study of the placenta should provide insight into the pathophysiology of preeclampsia. In this presentation we examine placental pathological and pathophysiological changes with preeclampsia and fetal growth restriction (FGR). It would seem that this comparison should be illuminating as both conditions are associated with similarly abnormal placentation yet only in preeclampsia is there a maternal pathophysiological syndrome. Similar insights about early and late onset preeclampsia should also be provided by such information.We report that the placental abnormalities in preeclampsia are what would be predicted in a setting of reduced perfusion and oxidative stress. However, the differences from FGR are inconsistent. The most striking differences between the two conditions are found in areas that have been the least studied. There are differences between the placental findings in early and late onset preeclampsia but whether these are qualitative, indicating different diseases, or simply quantitative differences within the same disease is difficult to determine.We attempt to decipher the true differences, seek an explanation for the disparate results and provide recommendations that we hope may help resolve these issues in future studies.

Entities:  

Year:  2012        PMID: 22745921      PMCID: PMC3381433          DOI: 10.1016/j.preghy.2012.01.001

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  105 in total

1.  Increased plasma adenosine concentrations and the severity of preeclampsia.

Authors:  Yoshio Yoneyama; Shunji Suzuki; Rintaro Sawa; Koichi Yoneyama; Gordon G Power; Tsutomu Araki
Journal:  Obstet Gynecol       Date:  2002-12       Impact factor: 7.661

2.  Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction.

Authors:  T M Mayhew; C Ohadike; P N Baker; I P Crocker; C Mitchell; S S Ong
Journal:  Placenta       Date:  2003 Feb-Mar       Impact factor: 3.481

Review 3.  'Omic' and hypothesis-driven research in the molecular pharmacology of cancer.

Authors:  John N Weinstein
Journal:  Curr Opin Pharmacol       Date:  2002-08       Impact factor: 5.547

4.  Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop pre-eclampsia later in pregnancy: implications for screening.

Authors:  Antonio Farina; Cinzia Zucchini; Paola De Sanctis; Danila Morano; Akihiko Sekizawa; Yuditiya Purwosunu; Takashi Okai; Nicola Rizzo
Journal:  Prenat Diagn       Date:  2011-01-04       Impact factor: 3.050

5.  Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction.

Authors:  D Schlembach; W Wallner; R Sengenberger; E Stiegler; M Mörtl; M W Beckmann; U Lang
Journal:  Ultrasound Obstet Gynecol       Date:  2007-04       Impact factor: 7.299

6.  Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction.

Authors:  Fàtima Crispi; Carmen Domínguez; Elisa Llurba; Pilar Martín-Gallán; Luís Cabero; Eduard Gratacós
Journal:  Am J Obstet Gynecol       Date:  2006-03-20       Impact factor: 8.661

7.  A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies.

Authors:  J W Meekins; R Pijnenborg; M Hanssens; I R McFadyen; A van Asshe
Journal:  Br J Obstet Gynaecol       Date:  1994-08

8.  Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation.

Authors:  B Huppertz; J Kingdom; I Caniggia; G Desoye; S Black; H Korr; P Kaufmann
Journal:  Placenta       Date:  2003 Feb-Mar       Impact factor: 3.481

9.  Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles.

Authors:  Sarah J Germain; Gavin P Sacks; Suren R Sooranna; Suren R Soorana; Ian L Sargent; Christopher W Redman
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

10.  Decidual arteriopathy in hypertension and diabetes in pregnancy: immunofluorescent studies.

Authors:  J L Kitzmiller; N Watt; S G Driscoll
Journal:  Am J Obstet Gynecol       Date:  1981-12-01       Impact factor: 8.661

View more
  126 in total

Review 1.  Low Birth Weight, Blood Pressure and Renal Susceptibility.

Authors:  Laura E Coats; Gwendolyn K Davis; Ashley D Newsome; Norma B Ojeda; Barbara T Alexander
Journal:  Curr Hypertens Rep       Date:  2019-06-21       Impact factor: 5.369

Review 2.  Tracking placental development in health and disease.

Authors:  John D Aplin; Jenny E Myers; Kate Timms; Melissa Westwood
Journal:  Nat Rev Endocrinol       Date:  2020-06-29       Impact factor: 43.330

3.  The MDM2 promoter T309G polymorphism was associated with preeclampsia susceptibility.

Authors:  Saeedeh Salimi; Abbas Mohammadpour-Gharehbagh; Mahnaz Rezaei; Mojtaba Sajadian; Batool Teimoori; Atefeh Yazdi; Mojgan Mokhtari; Minoo Yaghmaei
Journal:  J Assist Reprod Genet       Date:  2017-05-15       Impact factor: 3.412

Review 4.  Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.

Authors:  Juanjuan Chen; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-22       Impact factor: 3.622

5.  Heme oxygenase-1 is a potent inhibitor of placental ischemia-mediated endothelin-1 production in cultured human glomerular endothelial cells.

Authors:  Bhavisha A Bakrania; Frank T Spradley; Simon C Satchell; David E Stec; John M Rimoldi; Rama S V Gadepalli; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-12-06       Impact factor: 3.619

6.  Extracellular vesicles generated by placental tissues ex vivo: A transport system for immune mediators and growth factors.

Authors:  Wendy Fitzgerald; Nardhy Gomez-Lopez; Offer Erez; Roberto Romero; Leonid Margolis
Journal:  Am J Reprod Immunol       Date:  2018-05-04       Impact factor: 3.886

7.  Association of Wnt2 and sFRP4 expression in the third trimester placenta in women with severe preeclampsia.

Authors:  Zhan Zhang; Lin Zhang; Linlin Zhang; Liting Jia; Peng Wang; Yan Gao
Journal:  Reprod Sci       Date:  2013-01-15       Impact factor: 3.060

8.  Adenosine A2A receptor regulates expression of vascular endothelial growth factor in feto-placental endothelium from normal and late-onset pre-eclamptic pregnancies.

Authors:  Jesenia Acurio; Kurt Herlitz; Felipe Troncoso; Claudio Aguayo; Patricio Bertoglia; Carlos Escudero
Journal:  Purinergic Signal       Date:  2016-09-30       Impact factor: 3.765

9.  Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation.

Authors:  Shiqiu Xiong; Andrew M Sharkey; Philippa R Kennedy; Lucy Gardner; Lydia E Farrell; Olympe Chazara; Julien Bauer; Susan E Hiby; Francesco Colucci; Ashley Moffett
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

10.  Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia.

Authors:  J S Possomato-Vieira; R A Khalil
Journal:  Adv Pharmacol       Date:  2016-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.